Arrowhead Research Corporation Stock Prediction
AI-powered sentiment analysis and prediction trends for ARWR, updated each market day.
ARWR AI Sentiment
AI sees no strong directional signal for Arrowhead Research Corporation stock over the next 10 market days.
Prediction date: Oct. 9, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Arrowhead Research Corporation
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
Sector
Exchange
Market Cap
$9,151,876,916
Cap Tier
Employees
711
Headquarters
PASADENA, CA
Listed Since
Feb. 1, 1995
Website
ARWR Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ARWR Volatility
Arrowhead Research Corporation has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
